9.0K est. views
business1w ago

UK-based biotech firm Verona snapped up by Merck in $10bn deal

https://www.thetimes.com/business-money/technology/article/uk-based-biotech-firm-verona-snapped-up-by-merck-in-10bn-deal-gbwdtnclwhttps://www.merck.com/news/merck-to-acquire-verona-pharma-expanding-its-portfolio-to-include-ohtuvayre-ensifentrine-a-first-in-class-copd-maintenance-treatment-for-adults-and-expected-to-drive-growth-into-the-next-dec/https://www.cnbc.com/2025/07/09/merck-to-acquire-verona-pharma.html
Thetimes.com and 3 more
UK-based biotech firm Verona snapped up by Merck in $10bn deal Open in Thetimes.com
Vote 4
0

References

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade - Merck.com

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade - Merck.com

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck spends $10 billion for Verona, gaining access to its COPD medication

Merck spends $10 billion for Verona, gaining access to its COPD medication

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 560 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement